PCRX 17.55 (+0.98%)
US6951271005Drug ManufacturersDrug Manufacturers - Specialty & Generic

Pacira BioSciences (PCRX) Competitor Comparison

We are evaluating the key criteria listed to compare Pacira BioSciences (PCRX) against its competitors in the Drug Manufacturers - Specialty & Generic industry.

Linearity 10 years - PCRX ranking 34 / 54

These are the competitors of Pacira BioSciences in the industry Drug Manufacturers - Specialty & Generic ranked by linearity 10 years
1. ANI Pharmaceuticals ANIP
223.42
2. Theratechnologies THTX
123.17
3. Alvotech ALVO
16.13
4. ProPhase Labs PRPH
14.25
5. Evolus EOLS
13.95
6. Regencell Bioscience Holdings RGC
12.67
7. Eagle Pharmaceuticals EGRX
9.12
8. Phibro Animal Health PAHC
8.93
9. Avadel Pharmaceuticals AVDL
8.21
10. Alimera Sciences ALIM
7.61
11. Vifor Pharma G2AB.F
7.23
12. Emergent BioSolutions EBS
6.21
13. Linc LNC
5.55
14. PetIQ PETQ
5.4
15. Kolinpharma KIP.MI
4.84
16. Green Thumb Industries R9U2.F
4.39
17. Societal CDMO SCTL
3.72
18. Ayr Wellness 3KJB.F
3.68
19. Organogenesis Holdings ORGO
3.67
20. Ironwood Pharmaceuticals IRWD
3.63
21. Amneal Pharmaceuticals AMRX
3.29
22. Curaleaf Holdings CURLF
3.14
23. Cumberland Pharmaceuticals CPIX
3.11
24. Elanco Animal Health ELAN
3.04
25. Kamada KMDA
2.96
26. Journey Medical DERM
2.91
27. Taro Pharmaceutical Industries TARO
2.87
28. Tilray Brands TLRY
2.79
29. Cronos Group CRON
2.63
30. Procaps Group PROC
2.57
31. Catalent CTLT
2.51
32. Embecta EMBC
2.45
33. Neoleukin Therapeutics NLTX
2.29
34. Pacira BioSciences PCRX
2.22
35. Teva Pharmaceutical Industries TEVA
2.15
36. Perrigo PRGO
2.04
37. Alpha Teknova TKNO
1.91
38. Jupiter Wellness JUPW
1.84
39. Biofrontera BFRI
1.78
40. Flora Growth FLGC
1.77
41. Ascend Wellness Holdings AAWH
1.76
42. OptiNose OPTN
1.72
43. Zynerba Pharmaceuticals ZYNE
1.63
44. Clever Leaves Holdings CLVR
1.62
45. Universe Pharmaceuticals UPC
1.58
46. Relmada Therapeutics RLMD
1.57
47. Bausch Health Companies BHC
1.55
48. Solid Biosciences SLDB
1.5
49. SCYNEXIS SCYX
1.4
50. Collegium Pharmaceutical COLL
1.22
51. Supernus Pharmaceuticals SUPN
1.17
52. Zoetis ZTS
0.82
53. Harrow Health HROW
0.62
54. Amphastar Pharmaceuticals AMPH
0.49

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.